These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
2851 |
|
||||||||||||
|
(State or other jurisdiction of
incorporation or organization) |
(Primary Standard Industrial
Classification Code Number) |
(I.R.S. Employer
Identification No.) |
||||||||||||
|
|
|
|
||||||||||||
| (Title of class) | (Trading symbol) | (Exchange on which registered) | ||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
||||||||||||||||||||||
| Cost of goods sold |
|
|
||||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
||||||||||||||||||||||||
| Other operating charges |
|
|
||||||||||||||||||||||||
| Research and development expenses |
|
|
||||||||||||||||||||||||
| Amortization of acquired intangibles |
|
|
||||||||||||||||||||||||
| Income from operations |
|
|
||||||||||||||||||||||||
| Interest expense, net |
|
|
||||||||||||||||||||||||
| Other expense, net |
|
|
||||||||||||||||||||||||
| Income before income taxes |
|
|
||||||||||||||||||||||||
| Provision for income taxes |
|
|
||||||||||||||||||||||||
| Net income |
|
|
||||||||||||||||||||||||
| Less: Net loss attributable to noncontrolling interests |
|
(
|
||||||||||||||||||||||||
| Net income attributable to common shareholders | $ |
|
$ |
|
||||||||||||||||||||||
| Basic net income per share | $ |
|
$ |
|
||||||||||||||||||||||
| Diluted net income per share | $ |
|
$ |
|
||||||||||||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
| Net income | $ |
|
$ |
|
||||||||||||||||||||||
| Other comprehensive income (loss), before tax: | ||||||||||||||||||||||||||
| Foreign currency translation adjustments |
|
(
|
||||||||||||||||||||||||
| Unrealized gain on pension and other benefit plan obligations |
|
|
||||||||||||||||||||||||
| Other comprehensive income (loss), before tax |
|
(
|
||||||||||||||||||||||||
| Income tax (benefit) expense related to items of other comprehensive income |
(
|
|
||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax |
|
(
|
||||||||||||||||||||||||
| Comprehensive income (loss) |
|
(
|
||||||||||||||||||||||||
| Less: Comprehensive income (loss) attributable to noncontrolling interests |
|
(
|
||||||||||||||||||||||||
| Comprehensive income (loss) attributable to common shareholders | $ |
|
$ |
(
|
||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted cash |
|
|
||||||||||||
| Accounts and notes receivable, net |
|
|
||||||||||||
| Inventories |
|
|
||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, plant and equipment, net |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Identifiable intangibles, net |
|
|
||||||||||||
| Other assets |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities, Shareholders’ Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Current portion of borrowings |
|
|
||||||||||||
| Other accrued liabilities |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term borrowings |
|
|
||||||||||||
| Accrued pensions |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Other liabilities |
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
| Commitments and contingent liabilities (Note 5) |
|
|
||||||||||||
| Shareholders’ equity: | ||||||||||||||
|
Common shares, $
|
|
|
||||||||||||
| Capital in excess of par |
|
|
||||||||||||
| Retained earnings |
|
|
||||||||||||
|
Treasury shares, at cost,
|
(
|
(
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total Axalta shareholders’ equity |
|
|
||||||||||||
| Noncontrolling interests |
|
|
||||||||||||
| Total shareholders’ equity |
|
|
||||||||||||
| Total liabilities and shareholders’ equity | $ |
|
$ |
|
||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax benefit of $
|
— | — | — | — | — |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Total comprehensive income | — | — | — |
|
— |
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
— |
(
|
— | — | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | — | — | — |
|
— | — |
(
|
|
|||||||||||||||||||||||||||||||||||||||
|
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
|
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | — |
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Shares issued under compensation plans |
|
— |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||
| 2025 | 2024 | |||||||||||||
| Operating activities: | ||||||||||||||
| Net income | $ |
|
$ |
|
||||||||||
| Adjustment to reconcile net income to cash provided by operating activities: | ||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||
| Amortization of deferred financing costs and original issue discount |
|
|
||||||||||||
| Debt extinguishment and refinancing-related costs |
|
|
||||||||||||
| Deferred income taxes |
|
|
||||||||||||
| Realized and unrealized foreign exchange losses, net |
|
|
||||||||||||
| Stock-based compensation |
|
|
||||||||||||
| Interest income on swaps designated as net investment hedges |
(
|
(
|
||||||||||||
| Other non-cash, net |
(
|
|
||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||
| Trade accounts and notes receivable |
(
|
|
||||||||||||
| Inventories |
(
|
(
|
||||||||||||
| Prepaid expenses and other assets |
(
|
(
|
||||||||||||
| Accounts payable |
|
|
||||||||||||
| Other accrued liabilities |
(
|
(
|
||||||||||||
| Other liabilities |
(
|
|
||||||||||||
| Cash provided by operating activities |
|
|
||||||||||||
| Investing activities: | ||||||||||||||
| Acquisition, net of cash acquired |
(
|
|
||||||||||||
| Purchase of property, plant and equipment |
(
|
(
|
||||||||||||
| Interest proceeds on swaps designated as net investment hedges |
|
|
||||||||||||
| Other investing activities, net |
|
|
||||||||||||
| Cash used for investing activities |
(
|
(
|
||||||||||||
| Financing activities: | ||||||||||||||
| Proceeds from long-term borrowings |
|
|
||||||||||||
| Payments on short-term borrowings |
|
(
|
||||||||||||
| Payments on long-term borrowings |
(
|
(
|
||||||||||||
| Financing-related costs |
|
(
|
||||||||||||
| Net cash flows associated with stock-based awards |
(
|
|
||||||||||||
| Other financing activities, net |
(
|
|
||||||||||||
| Cash used for financing activities |
(
|
(
|
||||||||||||
| Decrease in cash |
(
|
(
|
||||||||||||
| Effect of exchange rate changes on cash |
|
(
|
||||||||||||
| Cash at beginning of period |
|
|
||||||||||||
| Cash at end of period | $ |
|
$ |
|
||||||||||
| Cash at end of period reconciliation: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Restricted cash |
|
|
||||||||||||
| Cash at end of period | $ |
|
$ |
|
||||||||||
| Note | Page | |||||||
|
Performance
Coatings |
Mobility
Coatings |
Total | ||||||||||||||||||
| Balance at December 31, 2024 | $ |
|
$ |
|
$ |
|
||||||||||||||
| Goodwill from acquisitions |
|
|
|
|||||||||||||||||
| Foreign currency translation |
|
|
|
|||||||||||||||||
| Balance at March 31, 2025 | $ |
|
$ |
|
$ |
|
||||||||||||||
| March 31, 2025 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
| Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
| Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
| Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
| Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||||||||
| December 31, 2024 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
| Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
| Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
| Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
| Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
| Total | $ |
|
$ |
(
|
$ |
|
||||||||||||||||||||
| Remainder of 2025 | $ |
|
||||||
| 2026 |
|
|||||||
| 2027 |
|
|||||||
| 2028 |
|
|||||||
| 2029 |
|
|||||||
| 2030 |
|
|||||||
| 2025 Activity | ||||||||
| Balance at December 31, 2024 | $ |
|
||||||
| Expenses, net of changes to estimates |
|
|||||||
| Payments made |
(
|
|||||||
| Foreign currency translation |
|
|||||||
| Balance at March 31, 2025 | $ |
|
||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
|
Components of net periodic benefit cost:
|
||||||||||||||||||||||||||
| Net periodic benefit cost: | ||||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
||||||||||||||||||||||
| Interest cost |
|
|
||||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
||||||||||||||||||||||||
| Amortization of actuarial loss, net |
|
|
||||||||||||||||||||||||
| Net periodic benefit cost | $ |
|
$ |
|
||||||||||||||||||||||
| Restricted Stock Units |
Units
(in millions) |
Weighted Average
Fair Value |
||||||||||||
| Outstanding at January 1, 2025 |
|
$ |
|
|||||||||||
| Granted |
|
$ |
|
|||||||||||
| Vested |
(
|
$ |
|
|||||||||||
|
Forfeited
(1)
|
|
$ |
|
|||||||||||
| Outstanding at March 31, 2025 |
|
$ |
|
|||||||||||
| Performance Share Units |
Units
(in millions) |
Weighted Average
Fair Value |
||||||||||||
| Outstanding at January 1, 2025 |
|
$ |
|
|||||||||||
| Granted |
|
$ |
|
|||||||||||
|
Vested
(1)
|
|
$ |
|
|||||||||||
| Forfeited |
(
|
$ |
|
|||||||||||
| Outstanding at March 31, 2025 |
|
$ |
|
|||||||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
| Foreign exchange losses, net | $ |
|
$ |
|
||||||||||||||||||||||
|
Debt extinguishment and refinancing-related costs
(1)
|
|
|
||||||||||||||||||||||||
| Total | $ |
|
$ |
|
||||||||||||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||
| 2025 | 2024 | |||||||||||||
| Effective Tax Rate |
|
% |
|
% | ||||||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| (In millions, except per share data) | 2025 | 2024 | ||||||||||||||||||||||||
| Net income to common shareholders | $ |
|
$ |
|
||||||||||||||||||||||
| Basic weighted average shares outstanding |
|
|
||||||||||||||||||||||||
| Diluted weighted average shares outstanding |
|
|
||||||||||||||||||||||||
|
Net income per common share
(1)
:
|
||||||||||||||||||||||||||
| Basic net income per share | $ |
|
$ |
|
||||||||||||||||||||||
| Diluted net income per share | $ |
|
$ |
|
||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||
|
Accounts receivable - trade, net
(1)
|
$ |
|
$ |
|
||||||||||
| Notes receivable |
|
|
||||||||||||
|
Other
(2)
|
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||
| Finished products | $ |
|
$ |
|
||||||||||
| Semi-finished products |
|
|
||||||||||||
| Raw materials |
|
|
||||||||||||
| Stores and supplies |
|
|
||||||||||||
| Total | $ |
|
$ |
|
||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||
| Property, plant and equipment | $ |
|
$ |
|
||||||||||
| Accumulated depreciation |
(
|
(
|
||||||||||||
| Property, plant and equipment, net | $ |
|
$ |
|
||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||
| 2029 Dollar Term Loans | $ |
|
$ |
|
||||||||||
| 2027 Dollar Senior Notes |
|
|
||||||||||||
| 2029 Dollar Senior Notes |
|
|
||||||||||||
| 2031 Dollar Senior Notes |
|
|
||||||||||||
| Short-term and other borrowings |
|
|
||||||||||||
| Unamortized original issue discount |
(
|
(
|
||||||||||||
| Unamortized deferred financing costs |
(
|
(
|
||||||||||||
| Total borrowings, net |
|
|
||||||||||||
| Less: | ||||||||||||||
| Short-term borrowings |
|
|
||||||||||||
| Current portion of long-term borrowings |
|
|
||||||||||||
| Long-term debt | $ |
|
$ |
|
||||||||||
| Remainder of 2025 | $ |
|
||||||
| 2026 |
|
|||||||
| 2027 |
|
|||||||
| 2028 |
|
|||||||
| 2029 |
|
|||||||
| Thereafter |
|
|||||||
| Total borrowings |
|
|||||||
| Unamortized original issue discount |
(
|
|||||||
| Unamortized deferred financing costs |
(
|
|||||||
| Total borrowings, net | $ |
|
||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Prepaid expenses and other current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Other assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Investments in equity securities
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Other accrued liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Interest rate swaps
(2)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Contingent consideration |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Other liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cross-currency swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Long-term borrowings: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 2029 Dollar Term Loans |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| 2027 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| 2029 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| 2031 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Fair Value Using Significant Unobservable Inputs
(Level 3) |
||||||||
|
Beginning balance at December 31, 2024
|
$ |
|
||||||
| Business acquisition |
|
|||||||
| Foreign currency translation |
(
|
|||||||
|
Ending balance at March 31, 2025
|
$ |
|
||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||
| Derivatives in Cash Flow and Net Investment Hedges | Location of Loss (Gain) Recognized in Income on Derivatives | Net Amount of Loss Recognized in OCI on Derivatives | Amount of Gain Recognized in Income | Net Amount of Gain Recognized in OCI on Derivatives | Amount of Gain Recognized in Income | |||||||||||||||||||||||||||
|
Cross-currency swaps
|
Interest expense, net | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
|
Derivatives Not Designated as Hedging
Instruments under ASC 815 |
Location of Loss (Gain) Recognized in Income on Derivatives |
Three Months Ended
March 31, |
||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||
| Foreign currency forward contracts | Other expense, net | $ |
(
|
$ |
(
|
|||||||||||||||||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
|
Net sales
(1)
:
|
||||||||||||||||||||||||||
| Refinish | $ |
|
$ |
|
||||||||||||||||||||||
| Industrial |
|
|
||||||||||||||||||||||||
| Total Net sales Performance Coatings |
|
|
||||||||||||||||||||||||
| Light Vehicle |
|
|
||||||||||||||||||||||||
| Commercial Vehicle |
|
|
||||||||||||||||||||||||
| Total Net sales Mobility Coatings |
|
|
||||||||||||||||||||||||
| Total Net sales | $ |
|
$ |
|
||||||||||||||||||||||
| Segment Adjusted EBITDA: | ||||||||||||||||||||||||||
| Performance Coatings | $ |
|
$ |
|
||||||||||||||||||||||
| Mobility Coatings |
|
|
||||||||||||||||||||||||
| Total | $ |
|
$ |
|
||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||
| Investment in unconsolidated affiliates: | ||||||||||||||||||||||||||
| Performance Coatings | $ |
|
$ |
|
||||||||||||||||||||||
| Mobility Coatings |
|
|
||||||||||||||||||||||||
| Total | $ |
|
$ |
|
||||||||||||||||||||||
|
Three Months Ended
March 31, 2025 |
||||||||||||||||||||
| Performance Coatings | Mobility Coatings | Total | ||||||||||||||||||
|
Net sales
|
$ |
|
$ |
|
$ |
|
||||||||||||||
|
Segment cost of goods sold
(1)
|
|
|
|
|||||||||||||||||
|
Other segment items
(2)
|
|
|
|
|||||||||||||||||
| Segment Adjusted EBITDA | $ |
|
$ |
|
$ |
|
||||||||||||||
|
Three Months Ended
March 31, 2024 |
||||||||||||||||||||
| Performance Coatings | Mobility Coatings | Total | ||||||||||||||||||
|
Net sales
|
$ |
|
$ |
|
$ |
|
||||||||||||||
|
Segment cost of goods sold
(1)
|
|
|
|
|||||||||||||||||
|
Other segment items
(2)
|
|
|
|
|||||||||||||||||
| Segment Adjusted EBITDA | $ |
|
$ |
|
$ |
|
||||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
|
Segment Adjusted EBITDA
(1)
:
|
||||||||||||||||||||||||||
| Performance Coatings | $ |
|
$ |
|
||||||||||||||||||||||
| Mobility Coatings |
|
|
||||||||||||||||||||||||
| Total |
|
|
||||||||||||||||||||||||
| Interest expense, net |
|
|
||||||||||||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||||||||||||||
|
Debt extinguishment and refinancing-related costs
(a)
|
|
|
||||||||||||||||||||||||
|
Termination benefits and other employee-related costs
(b)
|
|
|
||||||||||||||||||||||||
|
Acquisition and divestiture-related costs
(c)
|
|
|
||||||||||||||||||||||||
|
Site closure costs
(d)
|
|
|
||||||||||||||||||||||||
|
Foreign exchange remeasurement losses
(e)
|
|
|
||||||||||||||||||||||||
|
Long-term employee benefit plan adjustments
(f)
|
|
|
||||||||||||||||||||||||
|
Stock-based compensation
(g)
|
|
|
||||||||||||||||||||||||
|
Environmental charge
(h)
|
|
|
||||||||||||||||||||||||
|
Other adjustments
(i)
|
|
(
|
||||||||||||||||||||||||
| Income before income taxes | $ |
|
$ |
|
||||||||||||||||||||||
| (1) | The primary measure of segment operating performance is Segment Adjusted EBITDA, which is defined as net income before interest, taxes, depreciation, amortization and select other items impacting operating results. These other items impacting operating results are items that management has concluded are (i) non-cash items included within net income, (ii) items the Company does not believe are indicative of ongoing operating performance or (iii) non-recurring, unusual or infrequent items that have not occurred within the last two years or we believe are not reasonably likely to recur within the next two years. Segment Adjusted EBITDA is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts and prior year financial results, providing a measure that management believes reflects the Company's core operating performance, which represents Segment EBITDA adjusted for the select items referred to above. | ||||
| (a) | Represents expenses and associated changes to estimates related to the prepayment, restructuring, and refinancing of our indebtedness, which are not considered indicative of our ongoing operating performance. | ||||
| (b) | Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other employee-related costs associated with restructuring programs and other employee-related costs. These amounts are not considered indicative of our ongoing operating performance. | ||||
| (c) | Represents acquisition and divestiture-related expenses and integration activities associated with our business combinations, all of which are not considered indicative of our ongoing operating performance. | ||||
| (d) | Represents costs related to the closure of certain manufacturing sites, which we do not consider indicative of our ongoing operating performance. | ||||
| (e) | Represents foreign exchange losses resulting from the remeasurement of assets and liabilities denominated in foreign currencies, net of the impacts of our foreign currency instruments used to hedge our balance sheet exposures. | ||||
| (f) | Represents the non-cash, non-service cost components of long-term employee benefit costs. | ||||
| (g) | Represents non-cash impacts associated with stock-based compensation. | ||||
| (h) | Represents costs related to certain environmental remediation activities, which are not considered indicative of our ongoing operating performance. | ||||
| (i) | Represents costs for certain non-operational or non-cash gains, unrelated to our core business and which we do not consider indicative of our ongoing operating performance. | ||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
| North America | $ |
|
$ |
|
||||||||||||||||||||||
| EMEA |
|
|
||||||||||||||||||||||||
| Asia Pacific |
|
|
||||||||||||||||||||||||
|
Latin America
(1)
|
|
|
||||||||||||||||||||||||
|
Total
(2)
|
$ |
|
$ |
|
||||||||||||||||||||||
| March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||
| North America | $ |
|
$ |
|
||||||||||||||||||||||
| EMEA |
|
|
||||||||||||||||||||||||
| Asia Pacific |
|
|
||||||||||||||||||||||||
|
Latin America
(1)
|
|
|
||||||||||||||||||||||||
|
Total
(3)
|
$ |
|
$ |
|
||||||||||||||||||||||
|
Unrealized
Currency Translation Adjustments |
Pension Plan
Adjustments |
Unrealized
Loss on Derivatives |
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||
|
Balance, December 31, 2024
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Current year deferrals to AOCI |
|
|
|
|
||||||||||||||||||||||
| Reclassifications from AOCI to Net income |
(
|
|
|
(
|
||||||||||||||||||||||
| Net Change |
|
|
|
|
||||||||||||||||||||||
|
Balance, March 31, 2025
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
|
Unrealized
Currency Translation Adjustments |
Pension Plan
Adjustments |
Unrealized
Gain (Loss) on Derivatives |
Accumulated
Other Comprehensive Loss |
|||||||||||||||||||||||
|
Balance, December 31, 2023
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| Current year deferrals to AOCI |
(
|
|
|
(
|
||||||||||||||||||||||
| Reclassifications from AOCI to Net income |
(
|
|
|
(
|
||||||||||||||||||||||
| Net Change |
(
|
|
|
(
|
||||||||||||||||||||||
|
Balance, March 31, 2024
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
| (In millions) |
Three Months Ended
March 31, |
2025 vs 2024 | ||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % change | ||||||||||||||||||||||||||||||||||||
| Performance Coatings | ||||||||||||||||||||||||||||||||||||||
| Refinish | $ | 511 | $ | 519 | (1.5) | % | ||||||||||||||||||||||||||||||||
| Industrial | 311 | 329 | (5.6) | % | ||||||||||||||||||||||||||||||||||
| Total Net sales Performance Coatings | 822 | 848 | (3.1) | % | ||||||||||||||||||||||||||||||||||
| Mobility Coatings | ||||||||||||||||||||||||||||||||||||||
| Light Vehicle | 340 | 342 | (0.8) | % | ||||||||||||||||||||||||||||||||||
| Commercial Vehicle | 100 | 104 | (3.2) | % | ||||||||||||||||||||||||||||||||||
| Total Net sales Mobility Coatings | 440 | 446 | (1.3) | % | ||||||||||||||||||||||||||||||||||
| Total Net sales | $ | 1,262 | $ | 1,294 | (2.5) | % | ||||||||||||||||||||||||||||||||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales
|
$ | 1,262 | $ | 1,294 | $ | (32) | (2.5) | % | ||||||||||||||||||||||||||||||||||||||||||
| Exchange rate effect | (2.7) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Volume effect | (1.5) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Impact of CoverFlexx | 1.1 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Price/Mix effect | 0.6 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales decreased primarily due to the following:
|
||
|
n
Unfavorable impacts of currency translation driven by fluctuations of the Mexican Peso, Euro and Brazilian Real, in each case compared to the U.S. Dollar
|
||
|
n
Lower sales volumes driven by Performance Coatings
|
||
|
Partially offset by:
|
||
|
n
Contributions from the CoverFlexx Acquisition
|
||
|
n
Higher average selling prices and favorable product mix driven by Mobility Coatings
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Cost of sales | $ | 829 | $ | 865 | $ | (36) | (4.2) | % | ||||||||||||||||||||||||||||||||||||||||||
| % of net sales | 65.7 | % | 66.8 | % | ||||||||||||||||||||||||||||||||||||||||||||||
|
Cost of sales decreased primarily due to the following:
|
||
|
n
Favorable impacts of currency translation of 2.6% driven by fluctuations of the Mexican Peso, Euro and Brazilian Real, in each case compared to the U.S. Dollar
|
||
|
n
Lower sales volumes driven by Performance Coatings, partially offset by contributions from the CoverFlexx Acquisition
|
||
|
n
Decreased costs of $5 million related to our multi-year enterprise resource planning (“ERP”) system implementation and productivity programs
|
||
|
n
Lower operating expenses
|
||
|
n
Lower variable input costs
|
||
|
Cost of sales as a percentage of net sales decreased primarily due to the following:
|
||
|
n
Decreased costs of $5 million related to our multi-year ERP system implementation and productivity programs
|
||
|
n
Lower operating expenses
|
||
|
n
Lower variable input costs
|
||
|
n
Higher average selling prices and favorable product mix driven by Mobility Coatings
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Selling, general and administrative expenses | $ | 202 | $ | 207 | $ | (5) | (2.4) | % | ||||||||||||||||||||||||||||||||||||||||||
|
Selling, general and administrative expenses decreased primarily due to the following:
|
||
|
n
Favorable impacts of currency translation of 2.4% driven by fluctuations of the Euro, Mexican Peso and Brazilian Real, in each case compared to the U.S. Dollar
|
||
|
n
Lower operating expenses
|
||
|
n
Decrease of $2 million in commissions resulting from lower sales volumes
|
||
|
Partially offset by:
|
||
|
n
Contributions from the CoverFlexx Acquisition
|
||
|
n
Increase of $1 million in bad debt expense
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Other operating charges | $ | 14 | $ | 61 | $ | (47) | (77.0) | % | ||||||||||||||||||||||||||||||||||||||||||
|
Other operating charges decreased primarily due to the following:
|
||
|
n
Decrease of $44 million in termination benefits and other employee-related costs primarily as a result of significantly higher costs associated with the 2024 Transformation Initiative in the prior year period
|
||
|
n
Decrease of $4 million from environmental remediation costs recognized in the prior year period
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Research and development expenses | $ | 17 | $ | 18 | $ | (1) | (5.6) | % | ||||||||||||||||||||||||||||||||||||||||||
|
Research and development expenses remained generally consistent and impacts of currency translation were immaterial when compared to the prior year period.
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Amortization of acquired intangibles | $ | 24 | $ | 22 | $ | 2 | 9.1 | % | ||||||||||||||||||||||||||||||||||||||||||
|
Amortization of acquired intangibles increased due to the following:
|
||
|
n
Increased amortization of $2 million associated with assets acquired in the past 12 months
|
||
|
n
Impacts of currency translation were immaterial when compared to the prior year period
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest expense, net | $ | 44 | $ | 54 | $ | (10) | (18.5) | % | ||||||||||||||||||||||||||||||||||||||||||
|
Interest expense, net decreased primarily due to the following:
|
||
|
n
Favorable impact of $9 million attributable to lower principal and decreased variable interest rate on our 2029 Dollar Term Loans
|
||
|
n
Increased benefit of $1 million from derivative instruments
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Other expense, net | $ | 3 | $ | 8 | $ | (5) | 62.5 | % | ||||||||||||||||||||||||||||||||||||||||||
|
Other expense, net decreased primarily due to the following:
|
||
|
n
$3 million debt extinguishment and refinancing-related costs recognized in the prior year period as part of the repricing of our 2029 Dollar Term Loans
|
||
|
n
Favorable impact of foreign exchange losses of $2 million when compared to the prior year period
|
||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||
| Income before income taxes | $ | 129 | $ | 59 | ||||||||||||||||||||||
| Provision for income taxes | 30 | 20 | ||||||||||||||||||||||||
|
Statutory income tax rate
(1)
|
15.0 | % | 21.0 | % | ||||||||||||||||||||||
|
Effective tax rate
|
23.0 | % | 33.9 | % | ||||||||||||||||||||||
| Effective tax rate vs. statutory income tax rate | 8.0 | % | 12.9 | % | ||||||||||||||||||||||
| (Favorable) Unfavorable Impact | ||||||||||||||||||||||||||
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
|
Items impacting the effective tax rate vs. statutory income tax rate
(1)
|
2025 | 2024 | ||||||||||||||||||||||||
|
Earnings generated in jurisdictions where the income tax rate is different from the statutory rate
(2)
|
$ | 2 | $ | (6) | ||||||||||||||||||||||
|
Changes in valuation allowance
(3)
|
8 | 16 | ||||||||||||||||||||||||
| Foreign exchange losses, net | (1) | (6) | ||||||||||||||||||||||||
|
Non-deductible expenses and interest
|
1 | 1 | ||||||||||||||||||||||||
| Changes in unrecognized tax benefits | (1) | 2 | ||||||||||||||||||||||||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales
|
$ | 822 | $ | 848 | $ | (26) | (3.1) | % | ||||||||||||||||||||||||||||||||||||||||||
| Volume effect | (2.4) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Exchange rate effect | (2.3) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Impact of CoverFlexx | 1.6 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 197 | $ | 196 | $ | 1 | 1.0 | % | ||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA Margin | 24.1 | % | 23.1 | % | ||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales decreased primarily due to the following:
|
||
|
n
Lower sales volumes across both end-markets
|
||
|
n
Unfavorable impacts of currency translation due primarily to fluctuations of the Euro and Mexican Peso, in each case, compared to the U.S. Dollar
|
||
|
Partially offset by:
|
||
|
n
Contributions from the CoverFlexx Acquisition
|
||
|
Adjusted EBITDA and Adjusted EBITDA margin increased primarily due to the following:
|
||
|
n
Decreased operating expenses
|
||
|
n
Decreased costs of $3 million related to our multi-year ERP system implementation and productivity programs compared to the prior year period
|
||
|
n
Contributions from the CoverFlexx Acquisition
|
||
|
Partially offset by:
|
||
|
n
Lower sales volumes across both end-markets
|
||
|
n
Unfavorable impacts of currency translation due primarily to fluctuations of the Mexican Peso and Euro, in each case, compared to the U.S. Dollar
|
||
|
Three Months Ended
March 31, |
2025 vs 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 440 | $ | 446 | $ | (6) | (1.3) | % | ||||||||||||||||||||||||||||||||||||||||||
| Exchange rate effect | (3.4) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Price/Mix effect | 1.8 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Volume effect | 0.3 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 73 | $ | 63 | $ | 10 | 14.5 | % | ||||||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA Margin | 16.5 | % | 14.2 | % | ||||||||||||||||||||||||||||||||||||||||||||||
|
Net sales decreased primarily due to the following:
|
||
|
n
Unfavorable impacts of currency translation driven by fluctuations of the Mexican Peso, Brazilian Real and Euro, in each case compared to the U.S. Dollar
|
||
|
Partially offset by:
|
||
|
n
Higher average selling prices and favorable product mix
|
||
|
n
Higher sales volumes driven by the light vehicle end-market
|
||
|
Adjusted EBITDA and Adjusted EBITDA margin increased primarily due to the following:
|
||
|
n
Higher average selling prices and favorable product mix
|
||
|
n
Decreased variable input costs
|
||
|
n
Decreased costs of $2 million related to our multi-year ERP system implementation and productivity programs compared to the prior year period
|
||
|
n
Decrease of $1 million in inventory charges from obsolescence, quality and yield loss from manufacturing compared to the prior year period
|
||
|
n
Higher sales volumes driven by the light vehicle end-market
|
||
|
Partially offset by:
|
||
|
n
Unfavorable impacts of currency translation driven by the weakening of the Mexican Peso and Brazilian Real, in each case compared to the U.S. Dollar
|
||
|
Three Months Ended
March 31, |
||||||||||||||
| (In millions) | 2025 | 2024 | ||||||||||||
| Net cash provided by (used for): | ||||||||||||||
| Operating activities: | ||||||||||||||
| Net income | $ | 99 | $ | 39 | ||||||||||
| Depreciation and amortization | 70 | 68 | ||||||||||||
| Amortization of deferred financing costs and original issue discount | 2 | 2 | ||||||||||||
| Debt extinguishment and refinancing-related costs | — | 3 | ||||||||||||
| Deferred income taxes | 8 | 6 | ||||||||||||
| Realized and unrealized foreign exchange losses, net | 8 | 9 | ||||||||||||
| Stock-based compensation | 5 | 6 | ||||||||||||
| Interest income on swaps designated as net investment hedges | (3) | (3) | ||||||||||||
| Other non-cash, net | (1) | 2 | ||||||||||||
| Net income adjusted for non-cash items | 188 | 132 | ||||||||||||
| Changes in operating assets and liabilities | (162) | (98) | ||||||||||||
| Operating activities | 26 | 34 | ||||||||||||
| Investing activities | (44) | (19) | ||||||||||||
| Financing activities | (8) | (82) | ||||||||||||
| Effect of exchange rate changes on cash | 8 | (9) | ||||||||||||
| Net increase (decrease) in cash | $ | (18) | $ | (76) | ||||||||||
|
EXHIBIT NO.
|
DESCRIPTION OF EXHIBITS
|
|||||||
| 10.1^* | ||||||||
| 10.2^* | ||||||||
| 10.3^* | ||||||||
| 10.4 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1† | ||||||||
| 32.2† | ||||||||
| 101 | INS - Inline XBRL Instance Document. The document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document | |||||||
| 101 | SCH - Inline XBRL Taxonomy Extension Schema Document | |||||||
| 101 | CAL - Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
| 101 | DEF - Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||
| 101 | LAB - Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
| 101 | PRE - Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| ^ | Denotes management contract or compensatory plan or arrangement. | |||||||
| * | Certain terms in this Exhibit have been redacted in accordance with Item 601(b)(10)(iv) of Regulation S-K. The Company agrees to furnish to the SEC an unredacted copy of this Exhibit to the SEC upon its request. | |||||||
| † | This certificate is being furnished solely to accompany the report pursuant to 18 U.S.C. Section 1350 and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. | |||||||
| AXALTA COATING SYSTEMS LTD. | |||||||||||
| Date: | May 7, 2025 | By: /s/ Chris Villavarayan | |||||||||
| Chris Villavarayan | |||||||||||
| Chief Executive Officer and President | |||||||||||
| (Principal Executive Officer) | |||||||||||
| Date: | May 7, 2025 | By: /s/ Carl D. Anderson II | |||||||||
| Carl D. Anderson II | |||||||||||
| Senior Vice President and Chief Financial Officer | |||||||||||
| (Principal Financial Officer) | |||||||||||
| Date: | May 7, 2025 | By: /s/ Anthony Massey | |||||||||
| Anthony Massey | |||||||||||
| Vice President and Global Controller | |||||||||||
| (Principal Accounting Officer) | |||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Snap-on Incorporated | SNA |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|